User Fee Revision Reduces Expected CDER Staffing Increases By 60%
This article was originally published in The Tan Sheet
Executive Summary
A revision of FDA's estimated revenues from user fees will reduce the expected additions in staff to the Center for Drug Evaluation & Research to 40% of previous estimates.